Understanding the FDA's new regulations for Lab Developed Tests (LDTs)
In the realm of modern medicine, diagnostic tests play a pivotal role in identifying and treating diseases. As technology advances, so...
top of page
- Apr 23
London Biotechnology Show
Fleet will be attending the London Biotechnology Show, taking place 8th and 9th May at Olympia. The London Biotechnology Show aims to be...
- Apr 23
Navigating Challenges in the Development of ADA Assays for Immunogenicity Studies
In the realm of biopharmaceutical development, understanding and mitigating the immunogenicity of therapeutic proteins is crucial for...
- Apr 18
Fleet Bioprocessing re-certified to Cyber Essentials
Fleet Bioprocessing has successfully been re-certified as meeting the standards of Cyber Essentials. Cyber Essentials is a Government...
- Apr 5
Choosing the Right Platform for ADA Assays in Immunogenicity Studies: A Critical Decision
In the realm of biopharmaceutical development, understanding and mitigating the immunogenicity of therapeutic proteins is paramount....
- Feb 26
Streamlining Success: The Compelling Reasons to Outsource Bioconjugation and Antibody Labelling
In the dynamic landscape of life sciences and diagnostics, bioconjugation and antibody labelling stand as critical processes in advancing...
bottom of page